TACE With Thermosensitive Nanogel Versus Embosphere for HCC

Clinical trial NCT06593964 · RECRUITING

Trial details

NCT number: NCT06593964
Sponsor: Zhongda Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Unresectable Hepatocellular Carcinoma

Start date: 2024-09-10
Primary completion: 2026-04-30
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.